Farag Kameel D. bought AKTX
June 24, 2026 · Form 4 insider transaction
Farag Kameel D. bought 1,395 shares of Akari Therapeutics, Plc at $9.32 per share, a transaction worth $13.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,395
Price
$9.32
Total value
$13.0K
InsiderFarag Kameel D.
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateJune 24, 2026
Filing dateJune 25, 2026
Shares owned after4,265
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.